Pre-order Enquiry
Request Free Sample
Global and United States Anti-Parkinson Drugs Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19049363 | Publishing Date : 01-Sep-2021 | No. of pages : 106
Detailed TOC of Global and United States Anti-Parkinson Drugs Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Parkinson Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dopaminergic
1.2.3 Dopamine Agonists
1.2.4 Enzyme Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-Parkinson Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Parkinson Drugs Market Perspective (2016-2027)
2.2 Anti-Parkinson Drugs Growth Trends by Regions
2.2.1 Anti-Parkinson Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-Parkinson Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Anti-Parkinson Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Anti-Parkinson Drugs Industry Dynamic
2.3.1 Anti-Parkinson Drugs Market Trends
2.3.2 Anti-Parkinson Drugs Market Drivers
2.3.3 Anti-Parkinson Drugs Market Challenges
2.3.4 Anti-Parkinson Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Parkinson Drugs Players by Revenue
3.1.1 Global Top Anti-Parkinson Drugs Players by Revenue (2016-2021)
3.1.2 Global Anti-Parkinson Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Anti-Parkinson Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-Parkinson Drugs Revenue
3.4 Global Anti-Parkinson Drugs Market Concentration Ratio
3.4.1 Global Anti-Parkinson Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Parkinson Drugs Revenue in 2020
3.5 Anti-Parkinson Drugs Key Players Head office and Area Served
3.6 Key Players Anti-Parkinson Drugs Product Solution and Service
3.7 Date of Enter into Anti-Parkinson Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Parkinson Drugs Breakdown Data by Type
4.1 Global Anti-Parkinson Drugs Historic Market Size by Type (2016-2021)
4.2 Global Anti-Parkinson Drugs Forecasted Market Size by Type (2022-2027)
5 Anti-Parkinson Drugs Breakdown Data by Application
5.1 Global Anti-Parkinson Drugs Historic Market Size by Application (2016-2021)
5.2 Global Anti-Parkinson Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-Parkinson Drugs Market Size (2016-2027)
6.2 North America Anti-Parkinson Drugs Market Size by Type
6.2.1 North America Anti-Parkinson Drugs Market Size by Type (2016-2021)
6.2.2 North America Anti-Parkinson Drugs Market Size by Type (2022-2027)
6.2.3 North America Anti-Parkinson Drugs Market Size by Type (2016-2027)
6.3 North America Anti-Parkinson Drugs Market Size by Application
6.3.1 North America Anti-Parkinson Drugs Market Size by Application (2016-2021)
6.3.2 North America Anti-Parkinson Drugs Market Size by Application (2022-2027)
6.3.3 North America Anti-Parkinson Drugs Market Size by Application (2016-2027)
6.4 North America Anti-Parkinson Drugs Market Size by Country
6.4.1 North America Anti-Parkinson Drugs Market Size by Country (2016-2021)
6.4.2 North America Anti-Parkinson Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Parkinson Drugs Market Size (2016-2027)
7.2 Europe Anti-Parkinson Drugs Market Size by Type
7.2.1 Europe Anti-Parkinson Drugs Market Size by Type (2016-2021)
7.2.2 Europe Anti-Parkinson Drugs Market Size by Type (2022-2027)
7.2.3 Europe Anti-Parkinson Drugs Market Size by Type (2016-2027)
7.3 Europe Anti-Parkinson Drugs Market Size by Application
7.3.1 Europe Anti-Parkinson Drugs Market Size by Application (2016-2021)
7.3.2 Europe Anti-Parkinson Drugs Market Size by Application (2022-2027)
7.3.3 Europe Anti-Parkinson Drugs Market Size by Application (2016-2027)
7.4 Europe Anti-Parkinson Drugs Market Size by Country
7.4.1 Europe Anti-Parkinson Drugs Market Size by Country (2016-2021)
7.4.2 Europe Anti-Parkinson Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-Parkinson Drugs Market Size (2016-2027)
8.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type
8.2.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Application
8.3.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-Parkinson Drugs Market Size by Region
8.4.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Parkinson Drugs Market Size (2016-2027)
9.2 Latin America Anti-Parkinson Drugs Market Size by Type
9.2.1 Latin America Anti-Parkinson Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Anti-Parkinson Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Anti-Parkinson Drugs Market Size by Type (2016-2027)
9.3 Latin America Anti-Parkinson Drugs Market Size by Application
9.3.1 Latin America Anti-Parkinson Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Anti-Parkinson Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Anti-Parkinson Drugs Market Size by Application (2016-2027)
9.4 Latin America Anti-Parkinson Drugs Market Size by Country
9.4.1 Latin America Anti-Parkinson Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Anti-Parkinson Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Parkinson Drugs Market Size (2016-2027)
10.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type
10.2.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application
10.3.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-Parkinson Drugs Market Size by Country
10.4.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-Parkinson Drugs Introduction
11.1.4 AbbVie Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Mylan Laboratories
11.2.1 Mylan Laboratories Company Details
11.2.2 Mylan Laboratories Business Overview
11.2.3 Mylan Laboratories Anti-Parkinson Drugs Introduction
11.2.4 Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.2.5 Mylan Laboratories Recent Development
11.3 Valeant Pharmaceuticals
11.3.1 Valeant Pharmaceuticals Company Details
11.3.2 Valeant Pharmaceuticals Business Overview
11.3.3 Valeant Pharmaceuticals Anti-Parkinson Drugs Introduction
11.3.4 Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.3.5 Valeant Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Anti-Parkinson Drugs Introduction
11.4.4 Novartis Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Anti-Parkinson Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Zambon Pharmaceuticals
11.6.1 Zambon Pharmaceuticals Company Details
11.6.2 Zambon Pharmaceuticals Business Overview
11.6.3 Zambon Pharmaceuticals Anti-Parkinson Drugs Introduction
11.6.4 Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.6.5 Zambon Pharmaceuticals Recent Development
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Details
11.7.2 Pfizer, Inc. Business Overview
11.7.3 Pfizer, Inc. Anti-Parkinson Drugs Introduction
11.7.4 Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.7.5 Pfizer, Inc. Recent Development
11.8 Hoffmann-La Roche
11.8.1 Hoffmann-La Roche Company Details
11.8.2 Hoffmann-La Roche Business Overview
11.8.3 Hoffmann-La Roche Anti-Parkinson Drugs Introduction
11.8.4 Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.8.5 Hoffmann-La Roche Recent Development
11.9 Merck & Co.
11.9.1 Merck & Co. Company Details
11.9.2 Merck & Co. Business Overview
11.9.3 Merck & Co. Anti-Parkinson Drugs Introduction
11.9.4 Merck & Co. Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.9.5 Merck & Co. Recent Development
11.10 Orion Pharma
11.10.1 Orion Pharma Company Details
11.10.2 Orion Pharma Business Overview
11.10.3 Orion Pharma Anti-Parkinson Drugs Introduction
11.10.4 Orion Pharma Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.10.5 Orion Pharma Recent Development
11.11 UCB
11.11.1 UCB Company Details
11.11.2 UCB Business Overview
11.11.3 UCB Anti-Parkinson Drugs Introduction
11.11.4 UCB Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.11.5 UCB Recent Development
11.12 Teva Pharmaceutical Industries Ltd.
11.12.1 Teva Pharmaceutical Industries Ltd. Company Details
11.12.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.12.3 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Introduction
11.12.4 Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.12.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.13 Vertical Pharmaceuticals, LLC
11.13.1 Vertical Pharmaceuticals, LLC Company Details
11.13.2 Vertical Pharmaceuticals, LLC Business Overview
11.13.3 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Introduction
11.13.4 Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.13.5 Vertical Pharmaceuticals, LLC Recent Development
11.14 ACADIA Pharmaceuticals Inc.
11.14.1 ACADIA Pharmaceuticals Inc. Company Details
11.14.2 ACADIA Pharmaceuticals Inc. Business Overview
11.14.3 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Introduction
11.14.4 ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021)
11.14.5 ACADIA Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and United States Anti-Parkinson Drugs Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Anti-Parkinson Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dopaminergic
Table 3. Key Players of Dopamine Agonists
Table 4. Key Players of Enzyme Inhibitors
Table 5. Key Players of Others
Table 6. Global Anti-Parkinson Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-Parkinson Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anti-Parkinson Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Anti-Parkinson Drugs Market Share by Regions (2016-2021)
Table 10. Global Anti-Parkinson Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Anti-Parkinson Drugs Market Share by Regions (2022-2027)
Table 12. Anti-Parkinson Drugs Market Trends
Table 13. Anti-Parkinson Drugs Market Drivers
Table 14. Anti-Parkinson Drugs Market Challenges
Table 15. Anti-Parkinson Drugs Market Restraints
Table 16. Global Anti-Parkinson Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Anti-Parkinson Drugs Market Share by Players (2016-2021)
Table 18. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Parkinson Drugs as of 2020)
Table 19. Ranking of Global Top Anti-Parkinson Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Anti-Parkinson Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anti-Parkinson Drugs Product Solution and Service
Table 23. Date of Enter into Anti-Parkinson Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Anti-Parkinson Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Anti-Parkinson Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Anti-Parkinson Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Anti-Parkinson Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Anti-Parkinson Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Anti-Parkinson Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Anti-Parkinson Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Anti-Parkinson Drugs Product
Table 66. AbbVie Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Mylan Laboratories Company Details
Table 69. Mylan Laboratories Business Overview
Table 70. Mylan Laboratories Anti-Parkinson Drugs Product
Table 71. Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 72. Mylan Laboratories Recent Development
Table 73. Valeant Pharmaceuticals Company Details
Table 74. Valeant Pharmaceuticals Business Overview
Table 75. Valeant Pharmaceuticals Anti-Parkinson Drugs Product
Table 76. Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 77. Valeant Pharmaceuticals Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Anti-Parkinson Drugs Product
Table 81. Novartis Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Anti-Parkinson Drugs Product
Table 86. GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Zambon Pharmaceuticals Company Details
Table 89. Zambon Pharmaceuticals Business Overview
Table 90. Zambon Pharmaceuticals Anti-Parkinson Drugs Product
Table 91. Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 92. Zambon Pharmaceuticals Recent Development
Table 93. Pfizer, Inc. Company Details
Table 94. Pfizer, Inc. Business Overview
Table 95. Pfizer, Inc. Anti-Parkinson Drugs Product
Table 96. Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 97. Pfizer, Inc. Recent Development
Table 98. Hoffmann-La Roche Company Details
Table 99. Hoffmann-La Roche Business Overview
Table 100. Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 101. Hoffmann-La Roche Recent Development
Table 102. Merck & Co. Company Details
Table 103. Merck & Co. Business Overview
Table 104. Merck & Co. Anti-Parkinson Drugs Product
Table 105. Merck & Co. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 106. Merck & Co. Recent Development
Table 107. Orion Pharma Company Details
Table 108. Orion Pharma Business Overview
Table 109. Orion Pharma Anti-Parkinson Drugs Product
Table 110. Orion Pharma Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 111. Orion Pharma Recent Development
Table 112. UCB Company Details
Table 113. UCB Business Overview
Table 114. UCB Anti-Parkinson Drugs Product
Table 115. UCB Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 116. UCB Recent Development
Table 117. Teva Pharmaceutical Industries Ltd. Company Details
Table 118. Teva Pharmaceutical Industries Ltd. Business Overview
Table 119. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product
Table 120. Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 121. Teva Pharmaceutical Industries Ltd. Recent Development
Table 122. Vertical Pharmaceuticals, LLC Company Details
Table 123. Vertical Pharmaceuticals, LLC Business Overview
Table 124. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product
Table 125. Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 126. Vertical Pharmaceuticals, LLC Recent Development
Table 127. ACADIA Pharmaceuticals Inc. Company Details
Table 128. ACADIA Pharmaceuticals Inc. Business Overview
Table 129. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product
Table 130. ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million)
Table 131. ACADIA Pharmaceuticals Inc. Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Parkinson Drugs Market Share by Type: 2020 VS 2027
Figure 2. Dopaminergic Features
Figure 3. Dopamine Agonists Features
Figure 4. Enzyme Inhibitors Features
Figure 5. Others Features
Figure 6. Global Anti-Parkinson Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Stores Case Studies
Figure 10. Anti-Parkinson Drugs Report Years Considered
Figure 11. Global Anti-Parkinson Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anti-Parkinson Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-Parkinson Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Anti-Parkinson Drugs Market Share by Regions (2022-2027)
Figure 15. Global Anti-Parkinson Drugs Market Share by Players in 2020
Figure 16. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Parkinson Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2020
Figure 18. Global Anti-Parkinson Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Anti-Parkinson Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anti-Parkinson Drugs Market Share by Type (2016-2027)
Figure 22. North America Anti-Parkinson Drugs Market Share by Application (2016-2027)
Figure 23. North America Anti-Parkinson Drugs Market Share by Country (2016-2027)
Figure 24. United States Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anti-Parkinson Drugs Market Share by Type (2016-2027)
Figure 28. Europe Anti-Parkinson Drugs Market Share by Application (2016-2027)
Figure 29. Europe Anti-Parkinson Drugs Market Share by Country (2016-2027)
Figure 30. Germany Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anti-Parkinson Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anti-Parkinson Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anti-Parkinson Drugs Market Share by Region (2016-2027)
Figure 40. China Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anti-Parkinson Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Anti-Parkinson Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Anti-Parkinson Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anti-Parkinson Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anti-Parkinson Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anti-Parkinson Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 60. Mylan Laboratories Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 61. Valeant Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 64. Zambon Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 65. Pfizer, Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 66. Hoffmann-La Roche Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 67. Merck & Co. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 68. Orion Pharma Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 69. UCB Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 70. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 71. Vertical Pharmaceuticals, LLC Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 72. ACADIA Pharmaceuticals Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Keyplayers in Global and United States Anti-Parkinson Drugs Market Size, Status and Forecast 2021-2027
AbbVieMylan Laboratories
Valeant Pharmaceuticals
Novartis
GlaxoSmithKline
Zambon Pharmaceuticals
Pfizer, Inc.
Hoffmann-La Roche
Merck & Co.
Orion Pharma
UCB
Teva Pharmaceutical Industries Ltd.
Vertical Pharmaceuticals, LLC
ACADIA Pharmaceuticals Inc.
Request Sample
Request Discount
